1105TiPPembrolizumab plus chemoradiation (CRT) for the treatment of locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Phase 3 KEYNOTE-412 trial. (18th September 2017) - Machiels, J-P.; Licitra, L.; Rischin, D.; Waldron, J.; Burtness, B.; Grégoire, V.; Shekar, T.; Brown, H.M.; Cheng, J.; Siu, L.L.